APA (7th ed.) Citation

Palanisamy, N., Kalaghatgi, P., Akaberi, D., Lundkvist, A., Chen, Z., Hu, P., & Lennerstrand, J. (2018). Worldwide prevalence of baseline resistance-associated polymorphisms and resistance mutations in hepatitis C virus against current direct-acting antivirals. Antiviral therapy, 23(6), . https://doi.org/10.3851/IMP3237

Chicago Style (17th ed.) Citation

Palanisamy, Navaneethan, Prabhav Kalaghatgi, Dario Akaberi, Åke Lundkvist, Zhi-wei Chen, Peng Hu, and Johan Lennerstrand. "Worldwide Prevalence of Baseline Resistance-associated Polymorphisms and Resistance Mutations in Hepatitis C Virus Against Current Direct-acting Antivirals." Antiviral Therapy 23, no. 6 (2018). https://doi.org/10.3851/IMP3237.

MLA (9th ed.) Citation

Palanisamy, Navaneethan, et al. "Worldwide Prevalence of Baseline Resistance-associated Polymorphisms and Resistance Mutations in Hepatitis C Virus Against Current Direct-acting Antivirals." Antiviral Therapy, vol. 23, no. 6, 2018, https://doi.org/10.3851/IMP3237.